BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HWK-007 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HWK-007\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07444814-2525@assetmemo.bio
DTSTAMP:20261121T005453Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:HWK-007: Phase 1 readout est. (NCT07444814)
DESCRIPTION:HWK-007\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study E
 valuating the Safety and Efficacy of HWK-007\, a PTK7-directed Antibody Dr
 ug Conjugate in Participants With Advanced Solid Tumors\nEstimated primary
  completion: October 2028. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/hwk-007#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07444814
URL:https://assetmemo.bio/drug/hwk-007#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
